23Jan
Blog: Cooley's 2019 Life Sciences M&A Year in Review
2019 was a banner year for billion-dollar life sciences M&A transactions. A wave of big-ticket transactions by global pharmaceutical companies drove life sciences M&A activity to its fourth-largest year on record in 2019, with aggregate deal value in...
By:
Cooley LLP
Related
The Internal Revenue Service has announced the optional standard mileage rates for computing the ded...
Read More >
On December 12, 2019, for the first time in 60 years, the U.S. Department of Labor (DOL) announced a...
Read More >
The Legal 500 Adds Shook to Top Rankings in Cyber Law- The Legal 500 United States has again recogni...
Read More >
Q. My company has offices in Philadelphia and Pittsburgh. Is Pittsburgh’s new paid sick leave law ...
Read More >
Presented by Cohen Seglias attorney Michael F. McKenna on December 3, 2020. Over the past few decad...
Read More >
The California Consumer Privacy Act (CCPA), which took effect earlier this year, has left many emplo...
Read More >